Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 66131-74-6 | MDL No. : | MFCD20695001 |
Formula : | C5H7N5O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | VULZVYGZVOMUKU-UHFFFAOYSA-N |
M.W : | 153.14 | Pubchem ID : | 12429303 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 3.0 |
Molar Refractivity : | 38.94 |
TPSA : | 120.91 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.99 cm/s |
Log Po/w (iLOGP) : | 0.13 |
Log Po/w (XLOGP3) : | -1.06 |
Log Po/w (WLOGP) : | -1.24 |
Log Po/w (MLOGP) : | -1.55 |
Log Po/w (SILICOS-IT) : | -1.31 |
Consensus Log Po/w : | -1.01 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.46 |
Solubility : | 53.2 mg/ml ; 0.347 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.99 |
Solubility : | 15.7 mg/ml ; 0.102 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -0.51 |
Solubility : | 47.5 mg/ml ; 0.31 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.81 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 4786-53-2 ]
4-Hydroxypyrimidine-5-carboxamide
Similarity: 0.71
[ 1194961-19-7 ]
2-(((1R,2S)-2-Aminocyclohexyl)amino)-4-(m-tolylamino)pyrimidine-5-carboxamide
Similarity: 0.64
[ 1360443-21-5 ]
2-Chloro-N-methylpyrimidine-5-carboxamide
Similarity: 0.64
[ 23676-63-3 ]
N-((4-Amino-2-methylpyrimidin-5-yl)methyl)acetamide
Similarity: 0.63
[ 20781-06-0 ]
2,4-Diaminopyrimidine-5-carboxaldehyde
Similarity: 0.92
[ 15400-54-1 ]
Ethyl 2,4-diaminopyrimidine-5-carboxylate
Similarity: 0.73
[ 120747-84-4 ]
2-Aminopyrimidine-5-carbaldehyde
Similarity: 0.73
[ 1588441-19-3 ]
2-Aminopyrimidine-5-carbaldehyde hydrate
Similarity: 0.73
[ 4786-53-2 ]
4-Hydroxypyrimidine-5-carboxamide
Similarity: 0.71
[ 20781-06-0 ]
2,4-Diaminopyrimidine-5-carboxaldehyde
Similarity: 0.92
[ 15400-54-1 ]
Ethyl 2,4-diaminopyrimidine-5-carboxylate
Similarity: 0.73
[ 120747-84-4 ]
2-Aminopyrimidine-5-carbaldehyde
Similarity: 0.73
[ 1588441-19-3 ]
2-Aminopyrimidine-5-carbaldehyde hydrate
Similarity: 0.73
[ 4786-53-2 ]
4-Hydroxypyrimidine-5-carboxamide
Similarity: 0.71